TuHURA Biosciences Statistics
Total Valuation
HURA has a market cap or net worth of $99.44 million. The enterprise value is $97.45 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HURA has 51.26 million shares outstanding. The number of shares has decreased by -42.11% in one year.
| Current Share Class | 51.26M |
| Shares Outstanding | 51.26M |
| Shares Change (YoY) | -42.11% |
| Shares Change (QoQ) | +13.72% |
| Owned by Insiders (%) | 41.85% |
| Owned by Institutions (%) | 12.11% |
| Float | 28.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.03 |
| P/TBV Ratio | 33.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.40 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -47.12 |
Financial Efficiency
Return on equity (ROE) is -418.06% and return on invested capital (ROIC) is -80.80%.
| Return on Equity (ROE) | -418.06% |
| Return on Assets (ROA) | -60.16% |
| Return on Invested Capital (ROIC) | -80.80% |
| Return on Capital Employed (ROCE) | -150.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.54M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -69.11% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 2.80 |
| Relative Strength Index (RSI) | 44.69 |
| Average Volume (20 Days) | 175,789 |
Short Selling Information
The latest short interest is 2.35 million, so 4.59% of the outstanding shares have been sold short.
| Short Interest | 2.35M |
| Short Previous Month | 2.16M |
| Short % of Shares Out | 4.59% |
| Short % of Float | 8.14% |
| Short Ratio (days to cover) | 11.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.42M |
| Pretax Income | -29.29M |
| Net Income | -29.29M |
| EBITDA | -25.35M |
| EBIT | -25.42M |
| Earnings Per Share (EPS) | -$0.66 |
Full Income Statement Balance Sheet
The company has $2.70 million in cash and $706,514 in debt, giving a net cash position of $1.99 million or $0.04 per share.
| Cash & Cash Equivalents | 2.70M |
| Total Debt | 706,514 |
| Net Cash | 1.99M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 16.78M |
| Book Value Per Share | 0.32 |
| Working Capital | -5.33M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$24.67 million and capital expenditures -$69,641, giving a free cash flow of -$24.74 million.
| Operating Cash Flow | -24.67M |
| Capital Expenditures | -69,641 |
| Free Cash Flow | -24.74M |
| FCF Per Share | -$0.48 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |